HK1011867A1 - Antimicrobial cationic peptides and methods of screening for the same - Google Patents
Antimicrobial cationic peptides and methods of screening for the sameInfo
- Publication number
- HK1011867A1 HK1011867A1 HK98113071.8A HK98113071A HK1011867A1 HK 1011867 A1 HK1011867 A1 HK 1011867A1 HK 98113071 A HK98113071 A HK 98113071A HK 1011867 A1 HK1011867 A1 HK 1011867A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- entry
- row
- seq
- tryptophan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US268795P | 1995-08-23 | 1995-08-23 | |
PCT/IB1996/000996 WO1997008199A2 (en) | 1995-08-23 | 1996-08-23 | Antimicrobial cationic peptides and methods of screening for the same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1011867A1 true HK1011867A1 (en) | 1999-07-23 |
Family
ID=21701983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98113071.8A HK1011867A1 (en) | 1995-08-23 | 1998-12-10 | Antimicrobial cationic peptides and methods of screening for the same |
Country Status (10)
Country | Link |
---|---|
US (2) | US6191254B1 (xx) |
EP (1) | EP0846128B1 (xx) |
JP (1) | JP3860838B2 (xx) |
AT (1) | ATE412668T1 (xx) |
AU (1) | AU6940796A (xx) |
CA (1) | CA2230160A1 (xx) |
DE (1) | DE69637731D1 (xx) |
ES (1) | ES2316154T3 (xx) |
HK (1) | HK1011867A1 (xx) |
WO (1) | WO1997008199A2 (xx) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1174439B1 (en) * | 1996-08-21 | 2008-10-08 | Migenix Inc. | Compositions and methods for treating infections using analogues of indolicidin |
US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
US6180604B1 (en) | 1996-08-21 | 2001-01-30 | Micrologix Biotech Inc. | Compositions and methods for treating infections using analogues of indolicidin |
US6303575B1 (en) | 1998-05-12 | 2001-10-16 | The Regents Of The University Of California | Indolicidin analogs and methods of using same |
US6444645B1 (en) * | 1998-06-18 | 2002-09-03 | The Regents Of The University Of California | Crosslink-stabilized indolicidin analogs |
US6288212B1 (en) * | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
WO2000026344A1 (en) * | 1998-10-30 | 2000-05-11 | Interlink Biotechnologies Llc | Peptides with enhanced stability to protease degradation |
US6946261B1 (en) * | 1998-11-20 | 2005-09-20 | Migenix Inc. | Efficient methods for producing anti-microbial cationic peptides in host cells |
US6335318B1 (en) | 1999-05-10 | 2002-01-01 | The Regents Of The University Of California | Antimicrobial theta defensins and methods of using same |
US6497676B1 (en) | 2000-02-10 | 2002-12-24 | Baxter International | Method and apparatus for monitoring and controlling peritoneal dialysis therapy |
US6337317B1 (en) | 2000-06-27 | 2002-01-08 | The University Of British Columbia | Antimicrobial peptides and methods of use thereof |
US6835536B2 (en) | 2001-08-21 | 2004-12-28 | Micrologix Biotech Inc. | Antimicrobial cationic peptides and formulations thereof |
JP4511173B2 (ja) | 2001-08-24 | 2010-07-28 | マイジェニックス インコーポレイテッド | 抗菌性および抗炎症性ペプチド |
KR100438416B1 (ko) * | 2001-09-19 | 2004-07-02 | 학교법인조선대학교 | Ca-ma 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 + 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물 |
US7507787B2 (en) * | 2001-12-03 | 2009-03-24 | The University Of British Columbia | Effectors of innate immunity |
US20030125662A1 (en) * | 2002-01-03 | 2003-07-03 | Tuan Bui | Method and apparatus for providing medical treatment therapy based on calculated demand |
US20030219854A1 (en) * | 2002-03-21 | 2003-11-27 | Micrologix Biotech Inc. | Methods for producing modified anti-infective peptides |
WO2003091429A1 (fr) * | 2002-04-25 | 2003-11-06 | Toagosei Co.,Ltd. | Polypeptide microbicide et ses utilisations |
US7119070B2 (en) | 2002-04-30 | 2006-10-10 | The Regents Of The University Of California | Antimicrobial theta defensins, analogs thereof, and methods of use |
US7033769B2 (en) * | 2002-05-23 | 2006-04-25 | The United States Of America As Represented By The Secretary Of The Army | Method for discovering one or more peptides adapted for specific binding to a microorganism of interest |
US7238164B2 (en) * | 2002-07-19 | 2007-07-03 | Baxter International Inc. | Systems, methods and apparatuses for pumping cassette-based therapies |
WO2005019241A2 (en) * | 2003-08-18 | 2005-03-03 | E.I. Dupont De Nemours And Company | Cationic antimicrobial peptides and compositions thereof |
US7674771B2 (en) * | 2003-10-29 | 2010-03-09 | Toagosei Co., Ltd | Antimicrobial peptides and utilization of the same |
US20050209563A1 (en) * | 2004-03-19 | 2005-09-22 | Peter Hopping | Cassette-based dialysis medical fluid therapy systems, apparatuses and methods |
JP4507080B2 (ja) * | 2004-07-30 | 2010-07-21 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
JP4730584B2 (ja) * | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
EP1838331A4 (en) | 2004-12-15 | 2012-12-26 | Univ Colorado | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF |
WO2006088010A1 (ja) * | 2005-02-15 | 2006-08-24 | Toagosei Co., Ltd. | 抗菌ペプチド及びその利用 |
US7998115B2 (en) * | 2007-02-15 | 2011-08-16 | Baxter International Inc. | Dialysis system having optical flowrate detection |
US7731689B2 (en) | 2007-02-15 | 2010-06-08 | Baxter International Inc. | Dialysis system having inductive heating |
US8870812B2 (en) * | 2007-02-15 | 2014-10-28 | Baxter International Inc. | Dialysis system having video display with ambient light adjustment |
US8361023B2 (en) * | 2007-02-15 | 2013-01-29 | Baxter International Inc. | Dialysis system with efficient battery back-up |
US8558964B2 (en) | 2007-02-15 | 2013-10-15 | Baxter International Inc. | Dialysis system having display with electromagnetic compliance (“EMC”) seal |
CN101842107B (zh) * | 2007-07-26 | 2014-04-23 | 雷文斯治疗公司 | 抗微生物肽,组合物和使用方法 |
WO2010042534A1 (en) * | 2008-10-06 | 2010-04-15 | The Regents Of The University Of Colorado, A Body Corporate | Peptides and methods of use |
GB0821616D0 (en) * | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
US9352015B2 (en) * | 2009-06-05 | 2016-05-31 | The Regents Of The University Of Colorado, A Body Corporate | Antimicrobial peptides |
WO2011068801A2 (en) | 2009-12-01 | 2011-06-09 | The Rockefeller University | Methods for identifying compounds that modulate ion channel activity of a kir channel |
EP2558577B1 (en) | 2010-04-16 | 2018-12-12 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
WO2013039861A2 (en) | 2011-09-12 | 2013-03-21 | modeRNA Therapeutics | Engineered nucleic acids and methods of use thereof |
EP2834259A4 (en) | 2012-04-02 | 2016-08-24 | Moderna Therapeutics Inc | MODIFIED POLYNUCLEOTIDES |
CA2868391A1 (en) | 2012-04-02 | 2013-10-10 | Stephane Bancel | Polynucleotides comprising n1-methyl-pseudouridine and methods for preparing the same |
WO2013158773A2 (en) * | 2012-04-17 | 2013-10-24 | The Research Institute At Nationwide Children's Hospital | Rnase 7 antimicrobial peptides |
MY151307A (en) * | 2012-06-18 | 2014-05-05 | Univ Malaya | Peptides having antimicrobial activity |
GB201401877D0 (en) | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
EP3067608A1 (en) * | 2015-03-10 | 2016-09-14 | Abu Dhabi Polymers Co. Ltd (Borouge) LLC. | Eccentric polyolefin pipe |
AU2016353073A1 (en) | 2015-11-10 | 2018-06-07 | Visterra, Inc. | Antibody molecule-drug conjugates that specifically binds to lipopolysaccharide and uses thereof |
WO2018136626A1 (en) | 2017-01-18 | 2018-07-26 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
US11021529B2 (en) | 2017-03-03 | 2021-06-01 | Massachusetts Institute Of Technology | Antimicrobial constructs and uses thereof |
US10934943B2 (en) | 2017-04-27 | 2021-03-02 | General Electric Company | Compressor apparatus with bleed slot and supplemental flange |
US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
AU2021248643A1 (en) | 2020-04-03 | 2022-10-27 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
CU20200086A7 (es) * | 2020-11-19 | 2022-06-06 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028530A (en) | 1985-01-28 | 1991-07-02 | Xoma Corporation | AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
US5166321A (en) | 1985-01-28 | 1992-11-24 | International Genetic Engineering, Inc. | Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
US5206154A (en) | 1985-01-28 | 1993-04-27 | Xoma Corporation | Method of producing cecropins by microbiological techniques |
US4810777A (en) | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
US4822608A (en) | 1987-09-14 | 1989-04-18 | Vespa Laboratories, Inc. | Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof |
BR8907452A (pt) | 1988-05-27 | 1991-04-02 | Magainin Sciences Inc | Peptideo e polipeptideo antifilicos,processo e composicao para sua utilizacao |
SE8802939D0 (sv) | 1988-08-19 | 1988-08-19 | Kabigen Ab | A method for the production and isolation of a fusion protein in eukaryotic cells |
EP0440688B1 (en) | 1988-10-21 | 1994-09-21 | The Children's Hospital Of Philadelphia | Cpf peptide compositions and uses |
EP0441832B1 (en) | 1988-10-21 | 1994-06-15 | The Children's Hospital Of Philadelphia | Composition and treatment with biologically active peptides and certain anions |
US5217956A (en) | 1988-10-21 | 1993-06-08 | The Children's Hospital Of Philadelphia | Composition and treatment with biologically active peptides and certain anions |
CA2007913A1 (en) | 1989-01-30 | 1990-07-30 | Michael Zasloff | Composition and treatment with peptide combinations |
US5254535A (en) | 1989-04-17 | 1993-10-19 | The Children's Hospital Of Pennsylvania | Composition and treatment with biologically active peptides and antibiotic |
FR2646777B1 (fr) | 1989-05-12 | 1993-09-03 | Bio Serae Lab | Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications |
US5073542A (en) | 1989-06-07 | 1991-12-17 | Magainin Sciences Inc. | CPF peptide compositions and their use in inhibiting growth of target cells or a virus |
US5045531A (en) | 1989-12-18 | 1991-09-03 | Magainin Sciences Inc. | Wound treatment employing biologically active ion channel forming peptides and proteins |
JPH07504152A (ja) | 1990-02-08 | 1995-05-11 | マゲイニン ファーマスーティカルズ, インコーポレーテッド | 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法 |
US5227469A (en) | 1990-02-14 | 1993-07-13 | Genentech, Inc. | Platelet aggregation inhibitors from the leech |
JPH05509295A (ja) | 1990-04-23 | 1993-12-22 | マゲイニン サイエンセズ インコーポレーテッド | 生物学的に活性なペプチドおよび毒性陽イオンを有する組成物およびこれらを使用する治療法 |
EP0526570A4 (en) | 1990-04-27 | 1993-04-21 | Magainin Sciences, Inc. | Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
WO1991017760A1 (en) | 1990-05-14 | 1991-11-28 | Magainin Sciences Inc. | Composition of and treatment with biologically active peptides having d-amino acid residues |
US5208220A (en) | 1990-06-27 | 1993-05-04 | Magainin Pharmaceuticals, Inc. | Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase |
US5202420A (en) | 1990-10-25 | 1993-04-13 | The Children's Hospital Of Philadelphia | Tracheal antimicrobial peptides, dna sequences and methods for the production and use thereof |
US5235038A (en) | 1991-01-22 | 1993-08-10 | Torry Pines Institute For Molecular Studies | Deletion and substitution analogues of melittin peptide |
EP0579763A4 (en) | 1991-04-08 | 1994-12-21 | Magainin Pharma | NOVEL PEPTIDE COMPOSITIONS AND USES. |
WO1992022317A1 (en) | 1991-06-12 | 1992-12-23 | Magainin Pharmaceuticals, Inc. | Composition and treatment with biologically active peptides having c-terminal substitutions |
US5547939A (en) | 1991-06-14 | 1996-08-20 | The Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
US5324716A (en) * | 1991-06-14 | 1994-06-28 | Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
JPH07502979A (ja) | 1991-07-25 | 1995-03-30 | マゲイニン ファーマス−ティカルズ,インコーポレーテッド | 生物活性ペプチドを利用する口腔内の有害な状態の予防と治療 |
AU665030B2 (en) | 1991-09-13 | 1995-12-14 | Magainin Pharmaceuticals, Inc. | Biologically active amphiphilic peptide compositions and uses therefor |
AU3236293A (en) | 1991-12-09 | 1993-07-19 | Magainin Pharmaceuticals, Inc. | Composition and treatment with biologically active peptides and chelating agents |
CA2137087A1 (en) | 1992-06-01 | 1993-12-09 | U. Prasad Kari | Biologically active peptides having n-terminal substitutions |
EP0656952B1 (en) * | 1992-08-21 | 2003-03-05 | The University Of British Columbia | Cationic peptides and method for production |
CA2106720C (en) | 1992-09-23 | 1997-12-16 | Charles L. Deschenes | Needle for use as part of a plastic fastener dispensing tool |
US5635594A (en) * | 1994-03-11 | 1997-06-03 | University Of California, Los Angeles | Gallinacins - antibiotic peptides |
US5877274A (en) | 1995-06-02 | 1999-03-02 | University Of British Columbia | Antimicrobial cationic peptides |
-
1996
- 1996-08-23 EP EP96930303A patent/EP0846128B1/en not_active Expired - Lifetime
- 1996-08-23 DE DE69637731T patent/DE69637731D1/de not_active Expired - Lifetime
- 1996-08-23 US US08/702,054 patent/US6191254B1/en not_active Expired - Fee Related
- 1996-08-23 CA CA002230160A patent/CA2230160A1/en not_active Abandoned
- 1996-08-23 AU AU69407/96A patent/AU6940796A/en not_active Abandoned
- 1996-08-23 ES ES96930303T patent/ES2316154T3/es not_active Expired - Lifetime
- 1996-08-23 AT AT96930303T patent/ATE412668T1/de not_active IP Right Cessation
- 1996-08-23 WO PCT/IB1996/000996 patent/WO1997008199A2/en active Application Filing
- 1996-08-23 JP JP51006897A patent/JP3860838B2/ja not_active Expired - Fee Related
-
1998
- 1998-12-10 HK HK98113071.8A patent/HK1011867A1/xx not_active IP Right Cessation
-
2003
- 2003-03-28 US US10/403,104 patent/US7390873B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH11511971A (ja) | 1999-10-19 |
US6191254B1 (en) | 2001-02-20 |
US7390873B2 (en) | 2008-06-24 |
JP3860838B2 (ja) | 2006-12-20 |
WO1997008199A2 (en) | 1997-03-06 |
EP0846128A2 (en) | 1998-06-10 |
US20040019181A1 (en) | 2004-01-29 |
WO1997008199A3 (en) | 1997-09-12 |
ES2316154T3 (es) | 2009-04-01 |
ATE412668T1 (de) | 2008-11-15 |
AU6940796A (en) | 1997-03-19 |
EP0846128B1 (en) | 2008-10-29 |
DE69637731D1 (de) | 2008-12-11 |
CA2230160A1 (en) | 1997-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1011867A1 (en) | Antimicrobial cationic peptides and methods of screening for the same | |
NZ331758A (en) | Isolated dimeric fibroblast activation protein alpha and a method of cleaving a terminal dipeptide | |
ATE177752T1 (de) | Neue inhibitoren von faktor xa | |
TW281675B (xx) | ||
EP0670731A4 (en) | TREATMENT OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY THE DEPOSITION OF AMYLOID G (B) PROTEIN. | |
AU3951589A (en) | Peptide derivatives containing proline and leucine for use in affinity chromatography and a process for the preparation thereof | |
CA2217006A1 (en) | Novel substituted piperazine derivatives having tachykinin receptor antagonists activity | |
CA2211522A1 (en) | Novel compounds | |
AU5249898A (en) | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | |
UA43323C2 (uk) | Антибіотичні похідні глікопептидів, спосіб отримання та фармацевтична композиція | |
AU1383297A (en) | Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity | |
CA2293806A1 (en) | Alpha 1-antitrypsin preparation as well as a method for producing the same | |
ZA872298B (en) | A process for recovery of glycopeptidic antibiotics | |
CA2094347A1 (en) | A method of producing a factor viii preparation | |
DE69530404D1 (de) | Analogen des keratinozytenwachstumfaktors | |
AU6611696A (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives | |
AU5362190A (en) | Novel peptides, and antidementia agents containing the same | |
AU6710998A (en) | Process for preparing modified proteins | |
CA2196308A1 (en) | Peptide, bronchodilator and blood flow ameliorant | |
BR9609337A (pt) | Preparação de derivado de biciclohexano | |
EP0258203A3 (en) | Novel substrate peptides | |
IL122151A0 (en) | Purification of dalbaheptide antibiotics by isoelectric focusing | |
EP0853484A4 (en) | NEW LIGANDS OF MU OPIOID RECEPTORS: AGONISTS AND ANTAGONISTS | |
MX9403011A (es) | Nuevos compuestos derivados de la1,2-etanodiamina-n,n,n',n'-tetrasustituida. | |
ZA966371B (en) | The preparation of active peptides. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: CORRECTION OF THE NAME OF APPLICANT FROM THE UNIVERSITY OF BRITISH COLUMBIA TO UNIVERSITY OF BRITISH COLUMBIA |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120823 |